In contrast, heterozygous mutant (Pten+/−) mice developed neoplasia in multiple tissues, including mammary glands, lymphoid cells, small intestines, thyroid, endometrial, and adrenal glands [166,168,169], further limiting the applicability of the heterozygous mutant over Pten null mice. This evidence concerns the gene PTEN and neoplasm.